| pubmed-article:9407641 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9407641 | lifeskim:mentions | umls-concept:C0022687 | lld:lifeskim |
| pubmed-article:9407641 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:9407641 | lifeskim:mentions | umls-concept:C0920424 | lld:lifeskim |
| pubmed-article:9407641 | lifeskim:mentions | umls-concept:C2709199 | lld:lifeskim |
| pubmed-article:9407641 | lifeskim:mentions | umls-concept:C0005842 | lld:lifeskim |
| pubmed-article:9407641 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9407641 | pubmed:dateCreated | 1998-2-4 | lld:pubmed |
| pubmed-article:9407641 | pubmed:abstractText | Immunosuppression associated with blood transfusion may influence postoperative infection rates. It may also affect the prognosis of patients treated surgically for colorectal cancer. To control this effect, study protocols have applied autologous blood donation programs, which are thought to be immunologically neutral. However, evidence has emerged that blood donation itself might have suppressive effects on natural killer (NK) cell activities. At present, there are no data available on the effects of autologous blood transfusion on NK or lymphokine-activated killer (LAK) cells. This might be of interest as LAK cells may be active in tumor control. | lld:pubmed |
| pubmed-article:9407641 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9407641 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9407641 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9407641 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9407641 | pubmed:issn | 0042-9007 | lld:pubmed |
| pubmed-article:9407641 | pubmed:author | pubmed-author:SchildbergF... | lld:pubmed |
| pubmed-article:9407641 | pubmed:author | pubmed-author:AllgayerHH | lld:pubmed |
| pubmed-article:9407641 | pubmed:author | pubmed-author:JauchK WKW | lld:pubmed |
| pubmed-article:9407641 | pubmed:author | pubmed-author:HeissM MMM | lld:pubmed |
| pubmed-article:9407641 | pubmed:author | pubmed-author:WallnerSS | lld:pubmed |
| pubmed-article:9407641 | pubmed:author | pubmed-author:TarabichiAA | lld:pubmed |
| pubmed-article:9407641 | pubmed:author | pubmed-author:Fasol-MertenK... | lld:pubmed |
| pubmed-article:9407641 | pubmed:author | pubmed-author:StröhleinM... | lld:pubmed |
| pubmed-article:9407641 | pubmed:author | pubmed-author:EissnerH IHI | lld:pubmed |
| pubmed-article:9407641 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9407641 | pubmed:volume | 73 | lld:pubmed |
| pubmed-article:9407641 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9407641 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9407641 | pubmed:pagination | 237-45 | lld:pubmed |
| pubmed-article:9407641 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:meshHeading | pubmed-meshheading:9407641-... | lld:pubmed |
| pubmed-article:9407641 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9407641 | pubmed:articleTitle | Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. | lld:pubmed |
| pubmed-article:9407641 | pubmed:affiliation | Department of Surgery, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany. | lld:pubmed |
| pubmed-article:9407641 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9407641 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9407641 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9407641 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9407641 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9407641 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9407641 | lld:pubmed |
